Table 2 : Prevalence of cancer in male RLS cases and non cases according to
age group and study.
| DHS | SHIP-1 | COR- Study |
Cancer registry1 | |||
| Age group | RLS+ | RLS- | RLS+ | RLS- | RLS+ | -- |
| <34 years, % | 33.3 | 1.3* | 0 | 0 | 0 | 0.2 |
| 35-44 years, % | 0 | 0 | 0 | 0.8 | 0 | 0.5 |
| 45-54 years, % | 0 | 1.8 | 4.6 | 1.4 | 4.5 | 1.0* |
| 55-64 years, % | 7.1 | 2.0 | 5.0 | 4.5 | 8.6 | 3.2* |
| 65-74 years, % | 7.1 | 8.2 | 12.1 | 10.0 | 9.8 | 7.0 |
| 75+ years, % | -- | -- | 21.1 | 10.8 | 27.8 | 10.1* |
| TOTAL, % | 7.0 | 3.0 | 8.7 | 4.6* | 13.4 | 1.9* |
| OR, unadjusted (95% CI) |
2.45 (0.69-8.72) | 2.00 (1.00-4.00) | 8.23 (6.64-10.13) | |||
| OR, age adjusted (95% CI) |
1.98 (0.54-7.18) | 1.62 (0.79-3.31) | 2.44 (1.98-3.01) | |||
| Restricted to age group 25-74 years: | ||||||
| TOTAL, % | 7.0 | 3.0 | 6.3 | 3.7 | 8.2 | 1.4* |
| OR, unadjusted (95% CI) |
2.45 (0.69-8.72) | 1.76 (0.73-4.22) | 6.33 (4.59-8.54) | |||
| OR, age adjusted (95% CI) |
1.98 (0.54-7.18) | 1.31 (0.53-3.22) | 1.82 (1.35-2.47) | |||
*p<0.05 for the comparison within the age stratum (Chi Square Test)
¹RLS prevalence in the source population (n=1,280,314 in 2004) unknown